SMS Pharma Consolidated March 2020 Net Sales at Rs 96.47 crore, down 6.98% Y-o-Y
NULL08-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Outcome Of Board Meeting Held On 5Th June, 2020
1. Standalone Financial Results for the Quarter (Audited) and year ended (Audited) as on 31st March, 2020. 2. Consolidated financial results for the quarter (Audited) and year ended (Audited) Financial Results for the year ended as on 31st March, 2020. 3. Auditor's Report for Standalone and Consolidated Financial Statements. 4. Appointment of Mr. Vamsi Krishna Potluri as Additional Director, and designed as Executive Director.05-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 05.06.2020
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2020 ,inter alia, to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Friday 5th day of June, 2020, at the Registered Office of the Company, inter alia, for the following items: 1. To consider and approve the Audited Standalone and consolidated Quarterly results for the fourth Quarter ended on 31st March, 2020. 2. To consider and approve Standalone and Consolidated Annual Audited Financial Statements for the financial year ended on 31st March, 2020. 3. Appointment of Mr. Vamsi Krishna Potluri as Additional Director02-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - Disclosure Under Regulation 30 (3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015- Impact Of Covid-19.
The Company has been taking all precautions, adopting social distancing and other safety measures as per the Central & State Government as well as local administration guidelines across its operations in the Corporate office at Hyderabad and manufacturing facilities located at Andhra Pradesh & Telangana for prevention and containment of COVID-19.02-06-2020
SMS PHARMACEUTICALS LTD. - 532815 - ANNUAL DISCLOSURE OF ENCUMBRANCE OF SHARES BY PROMOTER REF: Regulation 31 (4) And (5) Of SEBI (SAST) Regulation, 2011
With reference to the subject cited above, please find enclosed the annual disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011 from Promoters of the Company dated May 27, 2020, for the financial year ended on March 31, 2020 for your kind perusal and Record.27-05-2020
SMS PHARMACEUTICALS LTD. - 532815 - Statement Under Regulation 40(9)&(10) For The Half Year Ended On 31St March, 2020.
Pursuant to the Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are submitting herewith a Compliance certificate issued by Mr. C. Sudhir Babu, practicing company secretary for the half year ended 31st March, 2020. Please take the same on your records.11-05-2020
SMS PHARMACEUTICALS LTD. - 532815 - Price Movement Clarification Ref: NSE/CM/Surveillance/9437 Dated 30Th April, 2020
With reference to clarification sought by your good office, we would like to inform you that the Company has made all necessary disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 and has not withheld any material information/ event that in our opinion would have bearing on the price behaviour of the scrip. The Company shall continue to make applicable disclosures, within the stipulated time.01-05-2020
SMS PHARMACEUTICALS LTD. - 532815 - Shareholding for the Period Ended March 31, 2020
SMS Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here30-04-2020
SMS PHARMACEUTICALS LTD. - 532815 - COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS)REGULATIONS, 2015
1. We the undersigned, hereby certify that all activities pertaining to transfer of equity shares both in physical and electronic form of the SMS Pharmaceuticals Limited for the period from 1st October, 2019 to 31st March, 2020 has been maintained by the Registrar & Share Transfer Agent (RTA & STA) M/s. AARTHI CONSULTANTS PRIVATE LIMITED (SEBI registration number INR000000379), having office at 1-2-285, Domalguda, Hyderabad, Telangana-500029 in effective and efficient manner. 2. This Certificate is issued in pursuance of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and should not be used for any other purpose.28-04-2020